Phase I Trial of VS-6766 Alone and in Combination With Everolimus

NCT02407509 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumours
Multiple Myeloma
Lung Cancer
Ovarian Cancer

Interventions

DRUG: VS-6766
DRUG: Everolimus

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]